Rhein Laser's UroFiber 60Q Receives FDA 510(k) Clearance, Redefining Urological Treatments
Rhein Laser Technologies Co., Ltd. has made a significant leap in the medical laser field with the announcement of FDA 510(k) clearance for its UroFiber® 60Q SuperPulsed Thulium Fiber Laser System, achieved on November 19, 2024. This marks a pioneering moment as Rhein Laser becomes the first Chinese enterprise to obtain FDA clearance for a thulium fiber laser, underscoring its commitment to delivering cutting-edge technologies in the medical arena.
UroFiber 60Q is distinguished by its remarkable performance enhancements over traditional fiber lasers. It boasts a 20% increase in laser peak power and a 15% rise in average output power. Such specifications translate to a superior treatment experience, especially in procedures like laser lithotripsy, where rapid fragmentation of stones is critical. The heightened output power not only expedites treatment but also significantly reduces collateral tissue damage, facilitating faster recovery for patients.
In addition to its prowess in stone treatments, the UroFiber 60Q excels in soft tissue applications, where its precision helps minimize bleeding and thermal injuries. As a result, patients benefit from shorter recovery periods and a safer overall treatment experience. The recent FDA clearance reaffirms the UroFiber 60Q’s safety and efficacy, sparking new growth avenues for Rhein Laser in the U.S. and beyond.
Rhein Laser is not resting on its laurels; plans for the UroFiber 150Q are already underway. This upgraded model features a water-cooled system with advanced specifications, including 10J of single laser pulse energy and a maximum output power of 150W. With these features, the UroFiber 150Q is positioned to set new benchmarks in urological laser technology and treatment efficacy.
Dr. Lin Yang, CEO of Rhein Laser, articulates the company’s vision: "Our research and development teams are strategically located in both Duesseldorf and Wuhan, merging German engineering precision with Chinese innovative strides. This unique synergy empowers us to redefine what’s possible in laser technology, ultimately designing solutions that enhance patient outcomes globally."
In an era when patient safety and treatment efficiency are paramount, UroFiber 60Q emerges as a transformative tool for the healthcare community, promising to elevate standards across urological procedures. Rhein Laser’s commitment to innovation, evidenced by their FDA clearance and advanced technology, positions them as a trailblazer in the field of medical lasers, paving the way for the future of urological care.
To learn more about the UroFiber laser system, visit www.UroFiber.com. For any inquiries, you can contact their media team via email.
UroFiber 60Q is distinguished by its remarkable performance enhancements over traditional fiber lasers. It boasts a 20% increase in laser peak power and a 15% rise in average output power. Such specifications translate to a superior treatment experience, especially in procedures like laser lithotripsy, where rapid fragmentation of stones is critical. The heightened output power not only expedites treatment but also significantly reduces collateral tissue damage, facilitating faster recovery for patients.
In addition to its prowess in stone treatments, the UroFiber 60Q excels in soft tissue applications, where its precision helps minimize bleeding and thermal injuries. As a result, patients benefit from shorter recovery periods and a safer overall treatment experience. The recent FDA clearance reaffirms the UroFiber 60Q’s safety and efficacy, sparking new growth avenues for Rhein Laser in the U.S. and beyond.
Rhein Laser is not resting on its laurels; plans for the UroFiber 150Q are already underway. This upgraded model features a water-cooled system with advanced specifications, including 10J of single laser pulse energy and a maximum output power of 150W. With these features, the UroFiber 150Q is positioned to set new benchmarks in urological laser technology and treatment efficacy.
Dr. Lin Yang, CEO of Rhein Laser, articulates the company’s vision: "Our research and development teams are strategically located in both Duesseldorf and Wuhan, merging German engineering precision with Chinese innovative strides. This unique synergy empowers us to redefine what’s possible in laser technology, ultimately designing solutions that enhance patient outcomes globally."
In an era when patient safety and treatment efficiency are paramount, UroFiber 60Q emerges as a transformative tool for the healthcare community, promising to elevate standards across urological procedures. Rhein Laser’s commitment to innovation, evidenced by their FDA clearance and advanced technology, positions them as a trailblazer in the field of medical lasers, paving the way for the future of urological care.
To learn more about the UroFiber laser system, visit www.UroFiber.com. For any inquiries, you can contact their media team via email.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.